Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

BACKGROUND: All Helicobacter pylori-infected patients are recommended for eradication with an appropriate regimen in each geographic area. The choice of the therapy is somewhat dependent on the antimicrobial susceptibility. The rate of clarithromycin resistance has been increasing and is associated...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Clin Microbiol Antimicrob
Hlavní autoři: Tanabe, Hiroki, Yoshino, Keiichi, Ando, Katsuyoshi, Nomura, Yoshiki, Ohta, Katsuhisa, Satoh, Kiichi, Ichiishi, Eiichiro, Ishizuka, Akiei, Otake, Takaaki, Kohgo, Yutaka, Fujiya, Mikihiro, Okumura, Toshikatsu
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022507/
https://ncbi.nlm.nih.gov/pubmed/29950163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-018-0281-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky